Study Summary
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cell therapy against CD7-positive hematological malignancies using CD7 specific CAR T cells. The study also aims to learn more about the function of CD7 CAR T cells and their persistence in patients of hematological malignancies.
Want to learn more about this trial?
Request More InfoInterventions
CD7-specific CAR gene-engineered T cellsBIOLOGICAL
Infusion of CD7-specific CAR-T cells
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Shenzhen Geno-immune Medical Institute | Shenzhen | Guangdong | China |